These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 16964306)

  • 1. Tobacco harm reduction in New Zealand.
    Laugesen M
    N Z Med J; 2006 Sep; 119(1241):U2161. PubMed ID: 16964306
    [No Abstract]   [Full Text] [Related]  

  • 2. Working with what we have before getting into bed with the tobacco industry.
    Bullen C; McRobbie H; Thornley S; Walker N; Whittaker R
    N Z Med J; 2006 Aug; 119(1240):U2139. PubMed ID: 16924284
    [No Abstract]   [Full Text] [Related]  

  • 3. Harm reduction policies for tobacco users.
    Gartner C; Hall W
    Int J Drug Policy; 2010 Mar; 21(2):129-30. PubMed ID: 19944582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of smokeless tobacco product marketing and use on population harm from tobacco use policy perspective for tobacco-risk reduction.
    Kozlowski LT
    Am J Prev Med; 2007 Dec; 33(6 Suppl):S379-86. PubMed ID: 18021913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Where to next with tobacco smokers?
    McCormick R; Sellman D; Robinson G
    N Z Med J; 2006 Jul; 119(1238):U2084. PubMed ID: 16868581
    [No Abstract]   [Full Text] [Related]  

  • 6. Does dual use jeopardize the potential role of smokeless tobacco in harm reduction?
    Frost-Pineda K; Appleton S; Fisher M; Fox K; Gaworski CL
    Nicotine Tob Res; 2010 Nov; 12(11):1055-67. PubMed ID: 20847148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smokeless tobacco: the epidemiology and politics of harm.
    Phillips CV; Heavner KK
    Biomarkers; 2009 Jul; 14 Suppl 1():79-84. PubMed ID: 19604065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiologic perspectives on smokeless tobacco marketing and population harm.
    Tomar SL
    Am J Prev Med; 2007 Dec; 33(6 Suppl):S387-97. PubMed ID: 18021914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are Australian smokers interested in using low-nitrosamine smokeless tobacco for harm reduction?
    Gartner CE; Jimenez-Soto EV; Borland R; O'Connor RJ; Hall WD
    Tob Control; 2010 Dec; 19(6):451-6. PubMed ID: 20671083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The incentives created by a harm reduction approach to smoking cessation: Snus and smoking in Sweden and Finland.
    Maki J
    Int J Drug Policy; 2015 Jun; 26(6):569-74. PubMed ID: 25214359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Commentary on Lund et al. (2011): Consolidating the evidence on effectiveness of snus for smoking cessation – implications for public health.
    Ramström L
    Addiction; 2011 Jan; 106(1):168-9. PubMed ID: 21618730
    [No Abstract]   [Full Text] [Related]  

  • 12. The complexity of 'harm reduction' with smokeless tobacco as an approach to tobacco control in low-income and middle-income countries.
    Ayo-Yusuf OA; Burns DM
    Tob Control; 2012 Mar; 21(2):245-51. PubMed ID: 22345261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tobacco, nicotine and harm reduction.
    Le Houezec J; McNeill A; Britton J
    Drug Alcohol Rev; 2011 Mar; 30(2):119-23. PubMed ID: 21375611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicotine electronic cigarette sales are permitted under the Smokefree Environments Act.
    Laugesen M
    N Z Med J; 2010 Jan; 123(1308):103-5. PubMed ID: 20173811
    [No Abstract]   [Full Text] [Related]  

  • 15. Smoking prevalence and tobacco control measures in Kenya, Uganda, the Gambia and Liberia: a review.
    Nturibi EM; Akinsola AK; McCurdy SA
    Int J Tuberc Lung Dis; 2009 Feb; 13(2):165-70. PubMed ID: 19146742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smokeless tobacco: a gateway to smoking or a way away from smoking.
    Melikian AA; Hoffmann D
    Biomarkers; 2009 Jul; 14 Suppl 1():85-9. PubMed ID: 19604066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Support for a tobacco endgame and increased regulation of the tobacco industry among New Zealand smokers: results from a National Survey.
    Edwards R; Wilson N; Peace J; Weerasekera D; Thomson GW; Gifford H
    Tob Control; 2013 May; 22(e1):e86-93. PubMed ID: 22535362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Supping with the devil? The role of law in promoting tobacco harm reduction using low nitrosamine smokeless tobacco products.
    Hall W; Gartner C
    Public Health; 2009 Mar; 123(3):287-91. PubMed ID: 19223052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High support for a tobacco endgame by Pacific peoples who smoke: national survey data.
    Wilson N; Edwards R; Thomson G; Weerasekera D; Talemaitoga A
    N Z Med J; 2010 Jun; 123(1316):131-4. PubMed ID: 20648111
    [No Abstract]   [Full Text] [Related]  

  • 20. Are smokers receptive to using smokeless tobacco as a substitute?
    Timberlake DS
    Prev Med; 2009; 49(2-3):229-32. PubMed ID: 19631684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.